When you think of small cap marijuana and cannabinoid stocks or players, GW Pharmaceuticals PLC (NASDAQ: GWPH) and Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) come to mind for those with big board listings while Cannabis Science Inc (OTCMKTS: CBIS) and Medical Marijuana Inc (OTCMKTS: MJNA) are well known OTC listed ones. However, there is a new cannabinoid stock with enormous potential that’s starting to find its way on to investor radar screens.
Small cap Vitality Biopharma, Inc. (OTCQB: STVFD) is dedicated to the development of cannabinoid prodrug pharmaceuticals and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. First, it should be said that Prodrugs are medications or compounds that, after administration, are converted within the body into a pharmacologically active drug. Prodrugs may be approved rapidly through demonstrating similar bioavailability or bioequivalence. They can also be far more marketable due to their ability